These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2214358)

  • 21. [Magnetic resonance of the encephalon in 17 patients with ocular Behçet's disease].
    Di Biasi C; Accorinti M; Trasimeni G; Pivetti Pezzi P; Melone A; Gualdi G
    Radiol Med; 1997 Apr; 93(4):348-51. PubMed ID: 9244909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multifocal ERG changes in patients with ocular Behçet's disease during therapy with interferon alpha 2a.
    Stübiger N; Besch D; Deuter CM; Zierhut M; Kötter I
    Adv Exp Med Biol; 2003; 528():529-32. PubMed ID: 12918757
    [No Abstract]   [Full Text] [Related]  

  • 23. Abnormal pattern electroretinogram in Alzheimer's disease: evidence for retinal ganglion cell degeneration?
    Katz B; Rimmer S; Iragui V; Katzman R
    Ann Neurol; 1989 Aug; 26(2):221-5. PubMed ID: 2774509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intravenous corticosteroid megadose treatment in ocular Behçet disease].
    Postelmans L; Verougstraete C; Libert J; Efira A; Caspers-Velu L
    Bull Soc Belge Ophtalmol; 1996; 262():95-103. PubMed ID: 9376926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Involvement of the optic nerve in the course of Behcet's disease (presentation of 148 cases)].
    Lamari H; Baha AT; Benhaddou M; Alikane O; Hamdani M; Zaghloul K; Amraoui A
    Bull Soc Belge Ophtalmol; 2003; (289):9-14. PubMed ID: 14619625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorescein iris angiography and anterior segment fluorophotometry in patients with Behçet's disease.
    Yoshikawa K; Takahashi Y; Ohsone T; Wakatsuki Y; Kogure M
    Jpn J Ophthalmol; 1987; 31(3):425-32. PubMed ID: 3430858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study).
    Davatchi F; Shams H; Rezaipoor M; Sadeghi-Abdollahi B; Shahram F; Nadji A; Chams-Davatchi C; Akhlaghi M; Faezi T; Naderi N
    Int J Rheum Dis; 2010 Aug; 13(3):246-52. PubMed ID: 20704622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of evoked potentials in multiple sclerosis and neuro-Behçet's syndrome.
    Nakamura Y; Takahashi M; Kitaguchi M; Imaoka H; Tarui S
    Electromyogr Clin Neurophysiol; 1989; 29(1):59-64. PubMed ID: 2702960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitrectomy for persistent panuveitis in Behçet's disease.
    Ahn JK; Chung H; Yu HG
    Ocul Immunol Inflamm; 2005 Dec; 13(6):447-53. PubMed ID: 16321889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma.
    Parisi V; Miglior S; Manni G; Centofanti M; Bucci MG
    Ophthalmology; 2006 Feb; 113(2):216-28. PubMed ID: 16406535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular manifestations of Behcet's disease in Indian patients.
    Rohatgi J; Singal A
    Indian J Ophthalmol; 2003 Dec; 51(4):309-13. PubMed ID: 14750618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An amplitude ratio of pattern visually evoked cortical potentials.
    Fujimoto N; Adachi-Usami E
    Acta Ophthalmol Scand; 1999 Apr; 77(2):157-9. PubMed ID: 10321530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ophthalmological involvement in Behçet disease. Apropos of 520 cases].
    el Belhadji M; Hamdani M; Laouissi N; Zaghloul K; Amraoui A; Benamour S
    J Fr Ophtalmol; 1997; 20(8):592-8. PubMed ID: 9515117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesenchymal stem cell therapy unable to rescue the vision from advanced Behcet's disease retinal vasculitis: report of three patients.
    Davatchi F; Nikbin B; Shams H; Sadeghi Abdollahi B; Mohyeddin M; Shahram F
    Int J Rheum Dis; 2013 Apr; 16(2):139-47. PubMed ID: 23773637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Electro-ophthalmological analysis of Behçet's disease].
    Asai H; Wakabayashi K; Segawa Y; Kawasaki K
    Nippon Ganka Gakkai Zasshi; 1989 Nov; 93(11):1038-43. PubMed ID: 2603853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Some observations on scotopic ERGs in Behcet's disease].
    Kase M; Aoki K; Fujioka K; Sugiura S
    Nippon Ganka Gakkai Zasshi; 1973; 77(4):400-7. PubMed ID: 4737846
    [No Abstract]   [Full Text] [Related]  

  • 37. [ERG in Behçet's disease (author's transl)].
    Hatt M; Niemeyer G
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1976 Feb; 198(2):113-20. PubMed ID: 1082724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pattern electroretinograms recorded with a skin electrode in pigmentary retinal degeneration.
    Adachi-Usami E; Murayama K
    Doc Ophthalmol; 1985 Oct; 61(1):33-9. PubMed ID: 4064888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High dose intravenous steroid therapy for severe posterior segment uveitis in Behçet's disease.
    Toker E; Kazokoğlu H; Acar N
    Br J Ophthalmol; 2002 May; 86(5):521-3. PubMed ID: 11973245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High dose methotrexate for ocular lesions of Behçet's disease. Preliminary short-term results.
    Davatchi F; Shahram F; Chams H; Jamshidi AR; Nadji A; Chams C; Akbarian M; Gharibdoost F
    Adv Exp Med Biol; 2003; 528():579-84. PubMed ID: 12918769
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.